Table 2.
Multivariate linear regression for association of Ln HOMA-IR with Ln OSI.
| Variable | Crude Model | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|
| β (95%CI) | P value | β (95%CI) | P value | β (95%CI) | P value | |
| Ln HOMA-IR | -0.39 (-0.45, -0.32) | <0.0001 | -0.14 (-0.21, -0.07) | <0.0001 | -0.18 (-0.25, -0.11) | <0.0001 |
| HOMA-IR tertile | ||||||
| T1 (< 2.32) | 0 (reference) | 0 (reference) | 0 (reference) | |||
| T 2 (2.32 - 3.87) | -0.25 (-0.34, -0.15) | <0.0001 | -0.07 (-0.17, 0.02) | 0.1164 | -0.10 (-0.19, -0.00) | 0.0391 |
| T 3 (> 3.87) | -0.57 (-0.67, -0.48) | <0.0001 | -0.21 (-0.31, -0.10) | 0.0002 | -0.25 (-0.36, -0.15) | <0.0001 |
| P for trend | <0.001 | <0.001 | <0.001 | |||
HOMA-IR, homeostatic model assessment of insulin resistance; Crude model adjust for none; Model 1 adjust for: age, BMI, AMH, and AFC; Model 2 adjusted for: age, BMI, AMH, basal FSH, initial Gn dose, AFC, and COS protocol.